Search the webpage

Category: Neuroprotection / glioprotection

Primary dissociated retinal cells offer a rapid and efficient way to assay the neuroprotective effects of drug candidates on retinal ganglion cells. Primary acutely dissociated retinal cell culture is prepared from adult Wistar rats and subjected to trophic factor withdrawal.

Cell viability is assessed by double-label immunocytochemistry using specific antibodies for Thy1 and neurofilament (NFL).



Rats (Wistar)

In vitro Insult

Trophic factor withdrawal


8 chamber well slides


Double label immunocytochemistry

Please contact us, if you would like to receive more information:


Thy1.1 and NFL immunoreactivities in primary acutely dissociated retinal cell culture

Two retinal ganglion cells in a field of view immunoreactive for Thy1.1 and NFL. Cells were exposed to a neuroprotective compound maintained under growth factor withdrawal conditions for 72 hr.


  • Burroughs SL, Duncan RS, Rayudu P, Kandula P, Payne AJ, Clark JL, Koulen P, Kaja S. Plate reader-based assays for measuring cell viability, neuroprotection and calcium in primary neuronal cultures. J Neurosci Methods. 2012,203(1):141-145. doi: 10.1016/j.jneumeth.2011.09.007.


  1. Kaja S, Duncan RS, Longoria S, Hilgenberg JD, Payne AJ, Desai NM, Parikh RA, Burroughs SL, Gregg EV, Goad DL, Koulen P. Novel mechanism of increased Ca2+ release following oxidative stress in neuronal cells involves type 2 inositol-1,4,5-trisphosphate receptors. Neuroscience. 2011,175:281-291. doi: 10.1016/j.neuroscience.2010.11.010.


Experimentica Ltd. opens a new R&D site in Lithuania

The investment totaling €1.6 million was supported, in part, by a competitive award “Smart FDI” (project no. 01.2.1-LVPA-T-848-01-005) under the ... Read More

Experimentica at BioJapan 2018

Experimentica Ltd. exhibits at BioJapan2018 partnering event in Pacifico Yokohama, Japan, on October 10 – October 12 ... Read More

Meet Experimentica Ltd. team at EVER 2018

Visit our booth to explore our state-of-the-art capabilities in preclinical research and our posters on diabetic retinopathy, glaucoma, dry and ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!